Warning Molina Healthcare, Inc. (MOH) optimists! Charles Fedak just Sold 4,487 shares.; Kadant Has 1.38 Sentiment

February 17, 2018 - By Henry Gaston

Kadant Inc. supplies equipment and components used in papermaking, paper recycling, recycling and waste management, and other process industries worldwide. The company has market cap of $1.07 billion. The firm operates in two divisions, Papermaking Systems and Wood Processing Systems. It has a 28.63 P/E ratio. The Papermaking Systems segment develops, makes, and markets custom-engineered stock-preparation systems and equipment for the preparation of wastepaper for conversion into recycled paper and balers, and related equipment used in the processing of recyclable and waste materials; and fluid-handling systems used primarily in the dryer section of the papermaking process and during the production of corrugated boxboard, metals, plastics, rubber, textiles, chemicals, and food.

Deal totalling a total of $325,532 US Dollars was published online in a legal document submitted to the SEC on February 16, 2018. According to which, Charles Fedak, the director of Molina Healthcare Inc also an insider of the firm had unloaded precisely 4,487 shares – ( at $72.6 for a share ). Presently, he owns a total of 20,648 shares or 0.03% of the Company’s total market cap.

Since August 17, 2017, it had 0 insider buys, and 25 insider sales for $47.42 million activity. Another trade for 32,689 shares valued at $3.00M was sold by MOLINA JOHN C. 66,000 Molina Healthcare, Inc. (NYSE:MOH) shares with value of $4.28M were sold by DENTINO WILLIAM. $971,190 worth of Molina Healthcare, Inc. (NYSE:MOH) was sold by MOLINA J MARIO MD on Tuesday, September 5. Another trade for 2,804 shares valued at $256,931 was made by BAYER TERRY on Friday, January 19. $60,000 worth of Molina Healthcare, Inc. (NYSE:MOH) was sold by ORLANDO STEVEN J. Shares for $18,633 were sold by ROMNEY RONNA on Friday, December 15. Another trade for 5,224 shares valued at $352,098 was made by Barlow Jeff D. on Monday, October 9.

Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. The company has market cap of $4.31 billion. It operates through three divisions: Health Plans, Molina Medicaid Solutions, and Other. It currently has negative earnings. The Health Plans segment operates health plans in 12 states.

Investors sentiment increased to 1.08 in 2017 Q3. Its up 0.04, from 1.04 in 2017Q2. It improved, as 43 investors sold Molina Healthcare, Inc. shares while 61 reduced holdings. 23 funds opened positions while 89 raised stakes. 58.60 million shares or 8.44% more from 54.04 million shares in 2017Q2 were reported. Lord Abbett Company Ltd Limited Liability Company has 0.1% invested in Molina Healthcare, Inc. (NYSE:MOH) for 500,304 shares. Thompson Davis Company invested 0.04% in Molina Healthcare, Inc. (NYSE:MOH). Ls Lc holds 1,878 shares or 0.01% of its portfolio. Robeco Institutional Asset Management Bv has 0.02% invested in Molina Healthcare, Inc. (NYSE:MOH) for 50,347 shares. Schroder Inv Gru has 0.01% invested in Molina Healthcare, Inc. (NYSE:MOH) for 123,445 shares. Profund Advsr Lc reported 0.02% in Molina Healthcare, Inc. (NYSE:MOH). New York State Teachers Retirement Sys reported 0.01% of its portfolio in Molina Healthcare, Inc. (NYSE:MOH). Citigroup has invested 0% of its portfolio in Molina Healthcare, Inc. (NYSE:MOH). Wells Fargo & Com Mn invested in 107,536 shares or 0% of the stock. Bancorp Of America Corp De reported 2.00 million shares. Geode Capital Management Lc holds 461,532 shares or 0.01% of its portfolio. Scout Invs Inc reported 431,041 shares. Cim Invest Mangement Inc invested in 0.12% or 4,779 shares. Hsbc Holding Plc owns 0% invested in Molina Healthcare, Inc. (NYSE:MOH) for 5,259 shares. Macquarie Group Inc Limited reported 1,300 shares.

Among 21 analysts covering Molina Healthcare (NYSE:MOH), 7 have Buy rating, 3 Sell and 11 Hold. Therefore 33% are positive. Molina Healthcare has $105 highest and $45 lowest target. $75.94’s average target is 5.30% above currents $72.12 stock price. Molina Healthcare had 54 analyst reports since July 31, 2015 according to SRatingsIntel. As per Wednesday, January 4, the company rating was initiated by Piper Jaffray. Cantor Fitzgerald maintained Molina Healthcare, Inc. (NYSE:MOH) rating on Thursday, September 3. Cantor Fitzgerald has “Hold” rating and $65 target. Credit Suisse initiated the shares of MOH in report on Wednesday, December 16 with “Neutral” rating. Goldman Sachs downgraded it to “Sell” rating and $45 target in Wednesday, May 4 report. The firm has “Hold” rating given on Friday, January 12 by Jefferies. The firm earned “Overweight” rating on Wednesday, February 7 by Morgan Stanley. The stock of Molina Healthcare, Inc. (NYSE:MOH) has “Buy” rating given on Tuesday, October 24 by Piper Jaffray. Barclays Capital maintained Molina Healthcare, Inc. (NYSE:MOH) rating on Tuesday, March 21. Barclays Capital has “Equal-Weight” rating and $51 target. The company was maintained on Thursday, February 15 by JP Morgan. Jefferies maintained Molina Healthcare, Inc. (NYSE:MOH) rating on Wednesday, February 14. Jefferies has “Hold” rating and $80.0 target.

Analysts await Molina Healthcare, Inc. (NYSE:MOH) to report earnings on February, 21. They expect $0.24 EPS, down 61.90% or $0.39 from last year’s $0.63 per share. MOH’s profit will be $14.33 million for 75.13 P/E if the $0.24 EPS becomes a reality. After $1.13 actual EPS reported by Molina Healthcare, Inc. for the previous quarter, Wall Street now forecasts -78.76% negative EPS growth.

The stock decreased 0.66% or $0.48 during the last trading session, reaching $72.12. About 1.31 million shares traded or 0.57% up from the average. Molina Healthcare, Inc. (NYSE:MOH) has risen 48.61% since February 17, 2017 and is uptrending. It has outperformed by 31.91% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 4 sales for $1.15 million activity.

Analysts await Kadant Inc. (NYSE:KAI) to report earnings on February, 22. They expect $1.08 earnings per share, up 56.52% or $0.39 from last year’s $0.69 per share. KAI’s profit will be $11.89M for 22.41 P/E if the $1.08 EPS becomes a reality. After $1.49 actual earnings per share reported by Kadant Inc. for the previous quarter, Wall Street now forecasts -27.52% negative EPS growth.

Phocas Financial Corp. holds 1.42% of its portfolio in Kadant Inc. for 171,207 shares. Alphaone Investment Services Llc owns 44,943 shares or 1.18% of their US portfolio. Moreover, Clean Yield Group has 1.09% invested in the company for 27,188 shares. The Connecticut-based Pier Capital Llc has invested 1.06% in the stock. Nine Chapters Capital Management Llc, a New Jersey-based fund reported 4,200 shares.

The stock decreased 0.62% or $0.6 during the last trading session, reaching $96.8. About 77,317 shares traded or 30.60% up from the average. Kadant Inc. (KAI) has risen 45.38% since February 17, 2017 and is uptrending. It has outperformed by 28.68% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Henry Gaston

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts